Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Anthony Lang And NotOntario

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000249 Werner Poewe [Autriche] ; Robert A. Hauser ; Anthony LangEffects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS.
000682 Caroline M. Tanner [États-Unis] ; Cheryl C. Meng ; Bernard Ravina ; Anthony Lang ; Roger Kurlan ; Kenneth Marek ; David Oakes ; John Seibyl ; Emily Flagg ; Lisa Gauger ; Dolores D. Guest ; Christopher G. Goetz ; Karl Kieburtz ; Diane Dieuliis ; Stanley Fahn ; Robin A. Elliott ; Ira ShoulsonA practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study.
000B69 Matthew B. Stern [États-Unis] ; Anthony Lang ; Werner Poewe [Autriche]Toward a redefinition of Parkinson's disease.
000B75 William Reginold [Canada] ; Melissa J. Armstrong ; Sarah Duff-Canning ; Anthony Lang ; David Tang-Wai ; Susan Fox ; Brandon Rothberg ; Cindy Zadikoff ; Nancy Kennedy ; David Gill ; Paul Eslinger ; Mark Mapstone ; Kelvin Chou ; Carol Persad ; Irene Litvan ; Benjamin Mast ; Connie MarrasThe pill questionnaire in a nondemented Parkinson's disease population.
000C64 Andrew Lees [Royaume-Uni] ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic [États-Unis] ; Anthony Lang ; Federico Micheli ; M Maral Mouradian ; Wolfgang H. Oertel ; C Warren Olanow ; Werner Poewe [Autriche] ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh KumarPerampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease.
001A53 Michael S. Okun [États-Unis] ; Anthony Lang [Canada] ; Joseph Jankovic [États-Unis]Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease
002A28 C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France]A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
004486 Anthony Lang ; Andrew Lees (neurologue) [Royaume-Uni]Editorial
006438 Koller [États-Unis] ; George F. Wong [États-Unis] ; Anthony Lang [Canada]Posttraumatic movement disorders: A review

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024